http://www.ncbi.nlm.nih.gov/pubmed/23151468
Clin Neuropharmacol. 2012 Nov-Dec;35(6):292-4. doi: 10.1097/WNF.0b013e31826ba0eb.
Orofacial dyskinesia after moxifloxacin treatment--a case with normal hepatorenal function and review of literature.
Mittal SO, Machado DG, Jabbari B.
Source
Department of Neurology, Yale University School of Medicine, New Haven, CT
Quote:
RESULTS:
Discontinuation of moxifloxacin and treatment with clonidine resulted in significant reduction of orofacial dyskinesia over the period of 8 to 12 weeks. A review of literature shows reports of a variety of involuntary movements with third-generation fluoroquinolones, mostly manifesting in patients with impaired renal and kidney function.
|
I did a little digging but found this... it pertains generally to the class of drug called
fluoroquinolones which includes Moxifloxacin (Avelox). I can't see specific mention of Moxifloxacin there but my eyes are playing tricks on me this morning.
Excerpt from book
Drug Induced Movement Disorders
Therapeutics of Parkinson's Disease and Other Movement Disorders
edited by Mark Hallett, Werner Poewe